Last update: 01/23/2023
1. Use of Site content
This Site is intended to present the activities of iBionext and to provide information on the products and services offered by iBionext and those of the start-ups in its ecosystem. The information contained on the Site is provided for information purposes only.
The presentation of information should not be considered as canvassing and does not constitute, under any circumstances, an offer of products or services, a recommendation or solicitation of an offer to purchase or a public offering. For information about any of iBionext’s products and/or services, or about any of the start-ups in its ecosystem, please contact iBionext directly.
Please note that any investment may present certain risks. Consequently, before making any investment decision, it is the responsibility of all investors to familiarize themselves with the regulatory documents in force.
iBionext draws your attention to the fact that past performance is no guarantee of future results, and investments may go down as well as up. Consequently, investors may not recover the amount initially invested, and there is no guarantee of income.
The laws and regulations of the country from which you access the Site may contain restrictions on the distribution of the information contained therein. In such cases, this information may not be distributed or used by any individual or legal entity, which would then be required to inform itself of and comply with such restrictions.
Apart from Personal Data, any information or content, in whatever form and nature, that you communicate to the Site by e-mail or otherwise, including any data, questions, comments, suggestions or ideas, shall be deemed to be non-confidential and iBionext shall have no obligation of any kind with respect to such information. iBionext shall be free to use any ideas, concepts, know-how, data or techniques contained in any such communications for any purpose whatsoever, including but not limited to developing its own products or services or those of any start-ups in its ecosystem.
2. Conflicts of interest
In application of the European Regulation “MiFID” (Markets in Financial Instruments Directive), iBionext has formalized a policy for managing conflicts of interest and implemented specific measures in terms of organization (means and procedures) and control to prevent, identify and manage situations of conflict of interest that could harm the interests of its clients. In this respect, iBionext attaches the utmost importance to the interests of its clients.
Thus, iBionext authorizes itself, depending on the conflict-of-interest situation, to:
carry out the activity or operation insofar as the organization makes it possible to manage the potential conflict of interest situation appropriately; and
inform the customer if any conflicts of interest arise and provide the necessary information on their nature and origin.
iBionext’s conflict of interest policy is available on request.
3. Intellectual property
The Site and its content, including but not limited to all visual elements, graphics, presentations, still or animated images, icons, photographs, videos, characters, sounds, content of any articles, press reviews, files, trademarks, logos, and more generally any information appearing on the Site, are the exclusive property of iBionext or third parties with whom iBionext has entered into agreements allowing reproduction and distribution.
Apart from use for strictly personal and non-commercial purposes by the user in accordance with the legislation in force, any reproduction, distribution and more generally any exploitation or use, in whole or in part, of the Site or its elements, are subject to the prior, express, and written authorization of iBionext.
The names, trademarks and logos associated with the Site, the products and services of iBionext or the start-ups in its ecosystem are registered and protected trademarks of iBionext, its start-ups, its/their partners or licensed to iBionext, unless otherwise stipulated. Any use of these names, trademarks and logos is subject to iBionext’s prior, express, and written authorization.
If permitted by the Site, you may download and/or copy the content of the Site for strictly personal, private and non-commercial use provided that (i) you do not remove, alter or modify any proprietary or copyright notices, (ii) you do not subsequently recopy, reproduce or otherwise redistribute the content and (iii) you do not interfere with or disrupt the operation of the Site and/or the servers and domains connected to the Site. Except for the foregoing, any copying, distribution, reproduction, representation, adaptation, modification, creation of derivative works, publication, republication, transmission, transfer, automatic use, translation, display, downloading, sale, disassembly, reverse engineering or other disposition of all or any part of the content or features of the Site, in any form and medium whatsoever and by any means whatsoever, is strictly prohibited without the prior, express and written consent of iBionext.
Any hypertext link from a third-party website to the Site or any of its pages requires iBionext’s express prior written consent.
In the absence of express authorization from iBionext to exploit or use the elements of the Site or to establish a link to the Site, the user is liable to prosecution.
4. Limitation of liability
The user acknowledges that he/she is fully aware that the information contained on the Site is not intended, in any way whatsoever, (i) to constitute an investment recommendation or advice based on the user’s specific circumstances or to meet his/her requirements, or (ii) to provide medical advice, make a diagnosis, or generally replace the consultation, advice or recommendations of a health professional.
While iBionext endeavors to provide accurate and up-to-date information on the Site, iBionext shall not be liable for any errors or omissions and makes no warranties, express or implied, as to the accuracy, fitness for any purpose, timeliness or completeness of the information contained on the Site.
iBionext does not warrant that the Site is free of errors or viruses or that it will operate without interruption. It is the user’s responsibility to take all necessary measures to protect his or her equipment and the data stored on it against any attack. iBionext declines all responsibility and cannot be held liable for any direct or indirect damage suffered by the user, in particular as a result of the loss, deterioration or alteration of files, or the transmission of viruses that may infect his or her computer equipment or any other property when connecting to and/or consulting and/or using the Site.
The Site may contain opinions of experts or other third parties, including extracts from press articles. Such information represents solely the views and opinions of its authors and not necessarily those of iBionext.
The Site may provide links to the websites of start-ups in its ecosystem and of third parties. These links are provided for information purposes only. iBionext has no control over these sites and accepts no responsibility for their content. Access to and use of these sites is under the sole and entire responsibility of the user, and in accordance with any conditions of use applicable to said sites.
5. Integration of sustainability risk (art. 5 SFDR)
At this stage, iBionext’s remuneration policy does not include sustainability risks. However, we are currently considering whether or not to include these risks in our remuneration policy, given the management company’s activities, size and regulatory status.
6. Applicable Law
The iBionext website is managed by iBionext SAS, a French Société par Actions Simplifiée (simplified joint-stock company) with capital of 250 000 euros, registered with the Paris Trade and Companies Register under the number 813 577 079. Adress of the registered office:74, rue du Faubourg Saint-Antoine, 75012 Paris, France. Phone number: +33 1 76 21 47 50.
iBionext SAS is a portfolio management company that has been approved by the Autorité des Marchés Financiers (www.amf-france.org) under the number #GP-15000031.
Head of Publication: Bernard Gilly
Hosting of ibionext.com: Siteground
Design and development: Xplore Digital
Images/Visuals: iBionext SAS